Menu
Recruiting NCT05974488

The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE

No phase Interventional Airway Obstruction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: McMurray Enhanced Airway, Nasal Cannula.
Who it may be relevant to
Registry conditions: Airway Obstruction. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Efficacy of Distal Pharyngeal Airway in Enhancing Oxygenation During Transesophageal Echocardiography (TEE) in Patients Sedated With Propofol

Overview

The purpose of this study is to investigate the effect of using the McMurray Enhanced Airway (MEA) which is a flexible extended-length distal pharyngeal airway on improving oxygen delivery compared to standard nasal cannula.

Interventions

  • Device McMurray Enhanced Airway
    The MEA is non-sterile. It can be used in inpatient or outpatient surgery, in hospital or clinic settings, or in an emergency setting. The MEA has five parts: an optional 15 mm connector, flange (color-coded for size), elongated cushioned bite block, flexible cannula, and distal tip, and a channel to allow for passage of air and a suction catheter. The MEA is designed to open and maintain a patient's upper airway. Oxygen will be delivered through the breathing circuit with the following paramete
  • Device Nasal Cannula
    Participants in this group will use the nasal cannula to deliver oxygen as per standard of care one time during the in-person visit.

Primary outcome measures

  • Incidence of hypoxia [Time frame: during procedure (up to 60 minutes)]
Secondary outcome measures (2)
  • Incidence of subclinical hypoxia [Time frame: during procedure (up to 60 minutes)]
  • Incidence of severe Hypoxia [Time frame: during procedure (up to 60 minutes)]

Eligibility criteria

Inclusion criteria

  • Age > or = 18 years old
  • Patients willing to participate and provide an informed consent
  • Patients scheduled to undergo an elective TEE procedure.

Exclusion criteria

  • Patients with history of uncontrolled gastroesophageal reflux disease
  • Patients with anatomical airway obstruction
  • Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Jackson Memorial Hospital — Miami

Identifiers

NCT: NCT05974488 · 20221246

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗